First on the list is Shukra Pharma. The company is engaged primarily in the business of manufacturing and marketing of pharmaceutical products. In 2025, the stock rallied 314%, rising from Rs 14.3 on ...

Separately, the bank's economists expect three rate cuts between now and the end of the year; lower rates are generally ...

Insider share ownership and corporate profitability are key to finding stocks that have been temporarily sold off Every December, a natural market dynamic creates bargains in the stock market. It's ...

Most investors spend their careers searching for a single magic formula. Know the right ratio. Find the perfect indicator. Discover the signal that turns ordinary returns into extraordinary wealth.

As we near 2026, investors should adopt an active approach when selecting stocks. This involves identifying breakout stocks within a specific price range. If the stock price dips below the lower band, ...

Seraphim Space Investment Trust (LSE:SSIT) was a penny share that was trading at 29p just over two years ago. But after benefitting from the recent space-tech boom, the trust has escaped penny-stock ...

For instance, researchers use the backyard sightings that users submit to Project FeederWatch —a joint program run by the Cornell Lab of Ornithology and Birds Canada —to track long-term changes in ...

Outside the U.S., valuation discounts are common. Entire countries, sectors, and market structures can trade at lower ...

After three straight years of robust returns, investors are asking, can stocks maintain their momentum in 2026?

C4 Therapeutics Inc. (NASDAQ:CCCC) is one of the best biotech penny stocks to buy according to analysts. On December 17, Barclays lowered the firm’s price target on C4 Therapeutics to $5 from $10, ...